EDGAR Filing Documents for 0001193125-15-078840

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-15-078840

Filing Date

2015-03-05

Accepted

2015-03-05 16:24:29

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d862236d10k.htm	10-K	1259159
2	EXHIBIT 23.1	d862236dex231.htm	EX-23.1	1425
3	EXHIBIT 31.1	d862236dex311.htm	EX-31.1	9431
4	EXHIBIT 31.2	d862236dex312.htm	EX-31.2	9419
5	EXHIBIT 32.1	d862236dex321.htm	EX-32.1	3134
6	EXHIBIT 32.2	d862236dex322.htm	EX-32.2	3182
13	GRAPHIC	g862236g99w56.jpg	GRAPHIC	109590
	Complete submission text file	0001193125-15-078840.txt		7654772

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	achn-20141231.xml	EX-101.INS	924679
8	XBRL TAXONOMY EXTENSION SCHEMA	achn-20141231.xsd	EX-101.SCH	63664
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	achn-20141231_cal.xml	EX-101.CAL	72498
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	achn-20141231_def.xml	EX-101.DEF	394570
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	achn-20141231_lab.xml	EX-101.LAB	494616
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	achn-20141231_pre.xml	EX-101.PRE	462078

Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511

Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000

ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)